Reliv’ International (OTCMKTS:RELV – Get Free Report) and Indivior (OTCMKTS:INVVY – Get Free Report) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings.
Insider and Institutional Ownership
7.8% of Reliv’ International shares are held by institutional investors. Comparatively, 0.1% of Indivior shares are held by institutional investors. 30.0% of Reliv’ International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Reliv’ International and Indivior’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Reliv’ International | -0.61% | -1.89% | -1.31% |
| Indivior | N/A | N/A | N/A |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Reliv’ International | $35.06 million | 0.11 | -$440,000.00 | ($0.09) | -25.00 |
| Indivior | $791.00 million | 3.81 | $205.00 million | $1.05 | 20.81 |
Indivior has higher revenue and earnings than Reliv’ International. Reliv’ International is trading at a lower price-to-earnings ratio than Indivior, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Reliv’ International and Indivior, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Reliv’ International | 0 | 0 | 0 | 0 | 0.00 |
| Indivior | 0 | 0 | 1 | 0 | 3.00 |
Indivior has a consensus target price of $50.00, suggesting a potential upside of 128.88%. Given Indivior’s stronger consensus rating and higher probable upside, analysts clearly believe Indivior is more favorable than Reliv’ International.
Volatility and Risk
Reliv’ International has a beta of -0.04, indicating that its share price is 104% less volatile than the S&P 500. Comparatively, Indivior has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500.
Summary
Indivior beats Reliv’ International on 12 of the 14 factors compared between the two stocks.
About Reliv’ International
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.
About Indivior
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.
Receive News & Ratings for Reliv' International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reliv' International and related companies with MarketBeat.com's FREE daily email newsletter.
